Pyrimidine derivatives

Details for Australian Patent Application No. 2007209126 (hide)

Owner AstraZeneca AB

Inventors Lambert-Van Der Brempt, Christine Marie Paul; Ducray, Richard; Read, Jon; Kettle, Jason Grant; Barlaam, Bernard Christophe; Leach, Andrew

Agent Davies Collison Cave

Pub. Number AU-B-2007209126

PCT Pub. Number WO2007/085833

Priority 60/762,387 26.01.06 US

Filing date 25 January 2007

Wipo publication date 2 August 2007

Acceptance publication date 19 January 2012

International Classifications

C07D 239/48 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61P 35/00 (2006.01) Antineoplastic agents

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

7 August 2008 PCT application entered the National Phase

  PCT publication WO2007/085833 Priority application(s): WO2007/085833

19 January 2012 Application Accepted

  Published as AU-B-2007209126

17 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007209128-Chewable capsules

2007209125-Methods and apparatus for monitoring software systems